666. Oncolytic Herpes Virotherapy Induces a Paracrine Death Signal Causing Synergistic Antitumor Efficacy with Aurora A Kinase Inhibition
Leslee Sprague(The Ohio State University), Timothy P. Cripe(Nationwide Children's Hospital), Meghan Franczek(Nationwide Children's Hospital), Joe Conner(Virttu Biologics (United Kingdom)), Tilat A. Rizvi(Cincinnati Children's Hospital Medical Center), Mark A. Currier(Nationwide Children's Hospital), Nancy Ratner(Cincinnati Children's Hospital Medical Center), Pin-Yi Wang(Nationwide Children's Hospital), Chun-Yu Chen(Kaohsiung Veterans General Hospital), Brooke Nartker(Nationwide Children's Hospital), Jeffrey Ecsedy(Howard Hughes Medical Institute), Brian Hutzen(Nationwide Children's Hospital)
Cited by 0
Related Papers
Formin-2, polyploidy, hypofertility and positioning of the meiotic spindle in mouse oocytes
|Nature Cell Biology|2002|329
Chronic Hydroxychloroquine Use Associated with QT Prolongation and Refractory Ventricular Arrhythmia
|Clinical Toxicology|2006|279
Intratumoral Injection of HSV1716, an Oncolytic Herpes Virus, Is Safe and Shows Evidence of Immune Response and Viral Replication in Young Cancer Patients
|Clinical Cancer Research|2017|137
Effective <i>in vivo</i> targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors
|Molecular Cancer Therapeutics|2008|128
Luteolin attenuates neutrophilic oxidative stress and inflammatory arthritis by inhibiting Raf1 activity
|Biochemical Pharmacology|2018|106